MSD Pharmaceutical Gets CDSCO Panel Nod To study MK-1084 Dr. Divya Colin17 Dec 2024 6:00 PM ISTNew Delhi: MSD Pharmaceutical has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control Organisation...
CDSCO panel approves AstraZeneca's Protocol Amendment proposal for Anticancer Drug AZD5305 study Dr. Divya Colin15 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Glenmark Pharmaceuticals Gets CDSCO Panel Nod To Import and Market anticancer Drug Zanubrutinib Capsules 80mg Dr. Divya Colin13 Dec 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Glenmark Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central...
Intas Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Anti-cancer Drug Pertuzumab Dr. Divya Colin1 Dec 2024 5:45 PM ISTNew Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel approves Roche Products' Polatuzumab Vedotin for Injection 30mg per vial for Diffuse large B-cell lymphoma Dr. Divya Colin30 Nov 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Roche's proposal...
CDSCO panel Approves AstraZeneca's Protocol Amendment proposal for Datopotamab Deruxtecan study Dr. Divya Colin7 Nov 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved AstraZeneca's...
Submit preclinical data in animal and Phase I CT data: CDSCO Panel Tells IQVIA on Pembrolizumab study Dr. Divya Colin2 Nov 2024 6:00 PM ISTNew Delhi: After reviewing the Phase I/III clinical study protocol of the anti-cancer drug Pembrolizumab, the Subject Expert Committee (SEC)...
AstraZeneca Gets CDSCO Panels Nod to study anticancer drug AZD0901 Dr. Divya Colin29 Oct 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Johnson & Johnson Gets CDSCO Panel Nod to Study anti-cancer drug Amivantamab Dr. Divya Colin26 Oct 2024 5:30 PM ISTNew Delhi: The drug major Johnson & Johnson has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
MSN Laboratories gets CDSCO Panel nod to conduct Bioequivalence Study of Abiraterone Tablets1000mg Dr. Divya Colin18 Aug 2024 5:45 PM ISTNew Delhi: MSN Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Bristol Myers Squibb India Gets CDSCO Panel Nod to Study anticancer drug Mezigdomide Dr. Divya Colin17 Aug 2024 6:00 PM ISTNew Delhi: The drug major Bristol-Myers Squib has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal to Study anti-cancer Drug Capivasertib Dr. Divya Colin28 July 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved AstraZeneca's...
